Han-I Wang
Senior Research Fellow (Health Economist)

Profile

Biography

Han-I is a research fellow in the York Trial Unit (YTU). She completed her Doctorate in health economics at the University of York in 2011 and worked in the Epidemiology Cancer Statistics Group (ECSG) (2011-2019) and the Mental Health and Addiction Research Group (MHARG) (2019-2023) before joining YTU in 2023.

Han-I specialises in economic evaluation, health outcomes research, and, more recently, climate change and sustainability. Her work often involves large, complex patient-level datasets and the application of advanced simulation techniques, including both cohort and individual-level models. In addition to her background in health economics, she is a trained data scientist and is actively incorporating machine learning and deep learning methods into health economic evaluation and outcomes research. She collaborates with academic teams and government organisations both within and beyond the University of York, working across the UK and internationally to support interdisciplinary research in this field

Qualifications

• MSc, Computer Science with artificial intelligence, University of York
• PhD, Health Economics, University of York
• MSc, Health Economics (with distinction) Taipei Medical University

Departmental roles

• Programme Lead- PGCert in Health Research and Statistics

Research

Overview

• Economic evaluation and health outcome research using complex patient level data
• Decision modelling/simulation research using real-world data
• Assessing both the efficiency and equity impact of health interventions through distributional cost-effectiveness analysis
• Application of deep learning techniques for clinical outcome prediction, cancer risk stratification, and healthcare needs forecasting
• Palliative / End-of-life care and place of death research

Projects

• ACTIVE - A RCT assessing the effectiveness of internal plate fixation versus external fine wire fixation for the management of Type C, closed pilon fractures of the distal tibia
• ASPECT - Alleviating Specific Phobias Experienced by Children Trial
• ASSSIST-2 – Social Stories for children with autism
• BASIL/BASIL+ - An RCT of the BASIL programme, a psychological intervention, for mitigating depression and loneliness during the Covid-19 pandemic in older people with long-term health conditions
• BAY - An RCT investigating behavioural activation for moderately to severely depressed young people in CAMHS settings.
• HAMLET - A multicentre, two-arm, non-blinded, pragmatic, parallel group, randomised controlled superiority trial assessing the clinical and cost effectiveness of Through Knee Amputation (TKA) compared to Above Knee Amputation (AKA) in patients requiring major lower limb amputations (MMLA), but who are unsuitable for a Below Knee Amputation (BKA).
• I-SOCIALISE - Investigating Social Competence and Isolation in children with Autism taking part in LEGO-based therapy clubs In School Environments
• MCLASS II - Muslim Communities Learning About Second-hand Smoke in Bangladesh
• MODS - A programme aiming to develop and evaluate an intervention to improve physical and psychological functioning in older adults with long-term physical health conditions and low mood or depression
• STIMULATE-ICP - Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways
• Trial Forge Studies Within a Trial (SWAT) centre

Research group(s)

• Trials and Statistics

Supervision

Han-I would be interested in supervising or co-supervising MSc and PhD students in the following areas: economic evaluation, cost analysis, health outcome research, decision modelling, big data analysis, and machine learning.

Publications

Full publications list

• Han-I Wang's publications

External activities

Memberships

• Member of International Society for Pharmacoeconomics and Outcomes Research (2012 onwards)
• Member of the End-of-life and Palliative Care Steering Group Committee (2014)

Teaching involvement outside the University of York

• Comparative Healthcare System, Taipei medical University (guest lecturer)
• Statistics, Ravensbourne University London (Guest lecturer)

Editorial duties

• Member of the editorial board for the Pharmacoeconomics journal (2021 - present)
• Reviewer for NIHR grants (2014 – present)

Invited talks and conferences

Invited Talks/Seminars

• 11/2022 Oral presentation, ISPOR Europe Conference, Austria: Cost and effectiveness of one session treatment (OST) for children and young people with specific phobias compared to multi-session cognitive behavioural therapy (CBT)
• 05/2021 Invited speaker, China: Advanced decision modeling in health economical evaluation
• 01/2020 Four-day Workshop, Brazil: Discrete event simulation for HTA
• 11/2019 Two-day short course, Tianjin University, China: Essentials of Market access & challenges in Health economics
• 09/2019 Invited speaker, Taipei Medical University, Taiwan: Advanced decision modeling in health economical evaluation
• 07/2019 Seminar, The National Institute for Health and Care Excellence (NICE), London, UK: ’Use of real world evidence in NICE Guideline development’
• 10/2018 Seminar, Centre of Health Economics (CHE), University of York, UK: Generic economic evaluation model for follicular lymphoma: predicting treatment cost, life expectancy and quality-adjusted-life-year for different scenarios using UK population based observational data’
• 09/2018 Workshop, 11th ISPOR Asia Pacific Conference: ‘Bridging the gap between efficacy and effectiveness: using both real-world and trial-based evidence to improve clinical decision making’
• 08/2018 Workshop, Peking University National School of Development, China: ‘Economic analysis of large medical databases’
• 09/2017 Seminar, Taipei Medical University, Taiwan : A generic economic evaluation model for follicular lymphoma: predicting treatment cost, life expectancy and quality adjusted life year for different scenarios using UK population based observational data’
• 09/2016 Invited speaker, Taipei Medical University, Taiwan: NHS in the UK
• 01/2016 Invited speaker, Bocconi University, Italy: Discrete event simulation
• 09/2015 Invited spears, National Health Insurance Administration, Taiwan: Decision modelling
• 01/2014 Invited speaker, National Health Insurance Administration, Taiwan: Health Technology Assessment (HTA) in the UK
• 01/2014 Invited speaker, National Institute of Health Technology Assessment, Taiwan: Micro-costing methods
• 05/2013 Workshop, Taipei Medical University, Taiwan: Constructing Markov model in Excel
• 05/2013 Invited speaker, Taipei Medical University, Taiwan: Long-term medical costs and life expectancy of acute myeloid leukaemia
• 11/2012 Invited speaker, University of Oslo, Norway: Decision modelling in excel, using “long-term medical costs and life expectancy of acute myeloid leukaemia" as an example

 Conferences

• 9th EuroQoL academy 2025 (Mar 2025)
• 26th ISPOR Annual European Congress (Nov 2024)
• 8th EuroQoL academy 2024 (Mar 2024)
• 25th ISPOR Annual European Congress (Nov 2023): poster award
• 24th ISPOR Annual European Congress (Nov 2022)
• 23rd ISPOR Annual European Congress (Nov 2021)
• ISPOR Asia Pacific 2018 (Sep 2018)
• 21th ISPOR Annual European Congress (Nov 2018): poster award
• 20th ISPOR Annual European Congress (Nov 2017)
• 21st ISPOR Annual International Meeting (May 2016)
• 18th ISPOR Annual European Congress (Nov 2015): poster award
• 17th ISPOR Annual European Congress (Nov 2014)
• 16th ISPOR Annual European Congress (Nov 2013)
• 15th ISPOR Annual European Congress (Nov 2012)
• 5th ISPOR Asia Pacific Conference 2012 (Sep 2012)

Teaching

Postgraduate

• Health Economics, University of York (Contributing lecturer)
• Research Methods, University of York (examiner)
• MSc Dissertation supervisor
• PhD TAP panel member